Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia
Results
Phase 2
This trial looked at a drug called blinatumomab for acute lymphoblastic leukaemia that has come back after or continued to get worse during treatment.
This study was for people with acute lymphoblastic leukaemia (ALL) that has the .
Recruitment start: 30 April 2014
Recruitment end: 12 January 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Adele Fielding
Amgen
Last reviewed: 09 Jan 2019
CRUK internal database number: 12069
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
